COVID-19 Clinical Trials in Phoenix

Showing 61-80 of 132 trials

COVID-19 Risk Assessment for Hospitalization Outcomes and Epidemiology Efficacy

NCT04678193

Researchers are creating real-time epidemiology registry to evaluate the efficacy of COVID-19 subject risk assessment scores based on recording of symptoms, biomarkers, chronic illness and mental health assessments with digital technology using wearables and mobile app tools. Researchers aim to study in Phase 1, epidemiological variations in COVID-19 presentation in both PCR positive and negative subjects in the registry. Assessment of variables, predictive modeling of variables that impact severity of COVID-19 positive and negative subjects and assessment of predictors for post COVID-19 complications. In Phase 2, 2700 subjects with COVID-19 positive test will be studied in the intervention group comparing ECL-19 vs placebo with primary end point of hospital admission assessment. Treatment strategy for PCR positive COVID-19 subjects in the registry who are in Stage I of the disease process with ECL-19 drug compared to placebo in reducing hospital admissions

Covid19

Aventyn, Inc.27,000 participantsStarted Dec 2020

Phoenix, Arizona, United States • Bangalore, India • Stockholm, Sweden

COMPLETEDPhase 3< 1 mile

Phase III Double-blind, Placebo-controlled Study of AZD1222 for the Prevention of COVID-19 in Adults

NCT04516746

The aim of the study is to assess the safety, efficacy, and immunogenicity of AZD1222 for the prevention of COVID-19.

COVID-19SARS-CoV-2

AstraZeneca32,450 participantsStarted Aug 2020

Phoenix, Arizona, United States • Scottsdale, Arizona, United States • Little Rock, Arkansas, United States +81 more locations

COVID-19 Risk Assessment for Hospitalization Outcomes and Epidemiology Efficacy

Phase III Double-blind, Placebo-controlled Study of AZD1222 for the Prevention of COVID-19 in Adults

COVID-19 Trials in Other Cities

Bucillamine in Treatment of Patients With COVID-19

Evaluation of Protease Inhibition for COVID-19 in Standard-Risk Patients (EPIC-SR).

Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for the Treatment of Ambulatory Adult and Pediatric Patients With COVID-19

Predictors of Severe COVID-19 Outcomes

VIR-7831 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

Phase III Study of AZD7442 for Treatment of COVID-19 in Outpatient Adults

Double-Blind, Randomized, Placebo-Controlled, Multi-Center Phase 3 Study to Evaluate the Efficacy and Safety of Fostamatinib in COVID-19 Subjects

Butterfly - Clinical Performance Study

PF-07304814 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

Real World Evaluation of the Effectiveness of AZD7442 for Prevention of SARS-CoV-2

Losmapimod Safety and Efficacy in COVID-19

PRE-VENT Study in Hospitalized Patients With Severe COVID-19 With or Without Cancer

Study of Sargramostim in Patients With COVID-19

Leidos-Enabled Adaptive Protocol (LEAP-CT) for Evaluation of Post-exposure Prophylaxis for Newly-infected COVID-19 Patients

Bioaerosol Sampling Device (BSD) Clinical Study

A Study Evaluating Tocilizumab in Pediatric Patients Hospitalized With COVID-19

Trial of Early Therapies During Non-hospitalized Outpatient Window for COVID-19

Examine the Psychosocial Impacts of COVID-19 Pandemic.

Other Conditions in Phoenix